Sökresultat - "Luining WI"

Early Oncological Outcomes in Patients who Underwent Staging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging Before Radical Prostatectomy and Extended Pelvic Lymph Node Dissection.

Ettema RH; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam, The Netherlands; Department of Nuclear Medicine, UMC Utrecht, Utrecht, The Netherlands; Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands. Electronic address: r.h.ettema@amsterdamumc.nl., Mellema JJ; Department of Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Meijer D; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., Oudshoorn FHK; Department of Urology, Spaarne Gasthuis Hospital, Haarlem, The Netherlands., Luining WI; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam, The Netherlands; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Donswijk ML; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van der Gaag S; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., Lam MGEH; Department of Nuclear Medicine, UMC Utrecht, Utrecht, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, The Netherlands., van den Bergh RCN; Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands.

Journal Article; Comparative Study , 2025

A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer.

Luining WI; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands. Electronic address: w.i.luining@amsterdamumc.nl., Boevé LMS; Department of Urology, OLVG, Amsterdam, The Netherlands., Hagens MJ; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Meijer D; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., de Weijer T; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Ettema RH; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., Knol RJJ; Department of Nuclear Medicine, Northwest Clinics, Alkmaar, The Netherlands., Roeleveld TA; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands; Department Urology, Northwest Clinics, Alkmaar, The Netherlands., Srbljin S; Department of Nuclear Medicine, Zaans Medical Center, Zaandam, The Netherlands., Weltings S; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands; Department of Urology, Zaans Medical Center, Zaandam, The Netherlands., Koppes JCC; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., van Leeuwen PJ; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Cysouw MCF; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands.

Journal Article; Comparative Study , 2025

Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences.

van Altena EJE; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands. Electronic address: e.vanaltena@amsterdamumc.nl., Jansen BHE; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., Korbee ML; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Northwest Clinics, Alkmaar, The Netherlands., Knol RJJ; Department of Nuclear Medicine, Northwest Clinics, Alkmaar, The Netherlands., Luining WI; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., Nieuwenhuijzen JA; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., van der Pas SL; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., van der Voort van Zyp JRN; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands., van der Zant FM; Department of Nuclear Medicine, Northwest Clinics, Alkmaar, The Netherlands., van Leeuwen PJ; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Wondergem M; Department of Nuclear Medicine, Northwest Clinics, Alkmaar, The Netherlands., Vis AN; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.

Journal Article , 2025

The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients-towards a tumor volume-based risk stratification.

Hagens MJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands. m.hagens@nki.nl.; Department of Urology, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands. m.hagens@nki.nl.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands. m.hagens@nki.nl., Luining WI; Department of Urology, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Boevé LMS; Department of Urology, OLVG, Amsterdam, The Netherlands., Knol RJJ; Department of Nuclear Medicine, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands., Roeleveld TA; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.; Department of Urology, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands., Srbljin S; Department of Nuclear Medicine, Zaans Medisch Centrum, Zaandam, The Netherlands., Weltings S; Department of Urology, Zaans Medisch Centrum, Zaandam, The Netherlands., Koppes JCC; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.

Journal Article , 2024

The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer.

Luining WI; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., Hagens MJ; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands.; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Meijer D; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., Ringia JB; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., de Weijer T; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Bektas HO; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Ettema RH; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., Knol RJJ; Department of Nuclear Medicine, Noordwest Hospital, Alkmaar, The Netherlands., Roeleveld TA; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands.; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department Urology, Noordwest Hospital, Alkmaar, The Netherlands., Srbljin S; Department of Nuclear Medicine, Zaans Medical Center, Zaandam, The Netherlands., Weltings S; Department of Urology, Zaans Medical Center, Zaandam, The Netherlands., Koppes JCC; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., van Leeuwen PJ; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands.; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands.

Journal Article , 2023

Optimization and validation of 18F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer.

Luining WI; Department of Urology, Amsterdam University Medical Centers, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Centers, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam University Medical Centers, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Knol RJJ; Department of Nuclear Medicine, Northwest Clinics, Alkmaar, The Netherlands., Wondergem M; Department of Nuclear Medicine, Northwest Clinics, Alkmaar, The Netherlands., Boellaard R; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Cysouw MCF; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands.

Multicenter Study; Journal Article , 2023

The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer.

Hagens MJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; m.hagens@nki.nl.; Department of Urology, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Luining WI; Department of Urology, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Jager A; Department of Urology, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Donswijk ML; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; and., Cheung Z; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; and., Wondergem M; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; and., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.

Journal Article , 2023

A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and ¹⁸ F-PSMA-PET/CT.

Bodar YJL; Department of Urology, Amsterdam University Medical Centres (VU University), Noord Holland, The Netherlands; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University), Noord Holland, The Netherlands; Prostate Cancer Network, Noord Holland, The Netherlands. Electronic address: y.j.bodar@amsterdamumc.nl., Luining WI; Department of Urology, Amsterdam University Medical Centres (VU University), Noord Holland, The Netherlands; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University), Noord Holland, The Netherlands; Prostate Cancer Network, Noord Holland, The Netherlands., Keizer B; Department of Urology, Dijklander Hospital, Noord Holland, The Netherlands., Meijer D; Department of Urology, Amsterdam University Medical Centres (VU University), Noord Holland, The Netherlands; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University), Noord Holland, The Netherlands; Prostate Cancer Network, Noord Holland, The Netherlands., Vellekoop A; Department of Urology, Amstelland Hospital, Noord Holland, The Netherlands., Schaaf M; Department of Urology, Bovenij hospital, Noord Holland, The Netherlands., Hendrikse NH; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University), Noord Holland, The Netherlands., Van Moorselaar RJA; Department of Urology, Amsterdam University Medical Centres (VU University), Noord Holland, The Netherlands; Prostate Cancer Network, Noord Holland, The Netherlands., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University), Noord Holland, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Centres (VU University), Noord Holland, The Netherlands; Prostate Cancer Network, Noord Holland, The Netherlands.

Multicenter Study; Journal Article , 2023

Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer.

Luining WI; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, VU University, 1081 HV Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, Location VUmc, 1081 HV Amsterdam, The Netherlands., Cysouw MCF; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, Location VUmc, 1081 HV Amsterdam, The Netherlands., Meijer D; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, VU University, 1081 HV Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, Location VUmc, 1081 HV Amsterdam, The Netherlands., Hendrikse NH; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, Location VUmc, 1081 HV Amsterdam, The Netherlands., Boellaard R; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, Location VUmc, 1081 HV Amsterdam, The Netherlands., Vis AN; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, VU University, 1081 HV Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, Location VUmc, 1081 HV Amsterdam, The Netherlands.

Journal Article; Review , 2022

Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers.

Luining WI; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, VU University, 1081 HV Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, VU University, 1081 HV Amsterdam, The Netherlands., Meijer D; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, VU University, 1081 HV Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, VU University, 1081 HV Amsterdam, The Netherlands., Dahele MR; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center, VU University Amsterdam, 1081 HV Amsterdam, The Netherlands., Vis AN; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, VU University, 1081 HV Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, VU University, 1081 HV Amsterdam, The Netherlands.

Journal Article; Review , 2021